Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

about

Antiproliferative Effects of Oxytocin and Desmopressin on Canine Mammary Cancer Cells.Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.

P2860

Q37531523-9A11B3B6-19D3-4B02-A648-903238F5541E Q38718417-4EB43EFA-0D36-43FB-BC7D-D45BF3460343

P2860

Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

Item

http://www.wikidata.org/entity/Q36919383

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Synergistic growth inhibitory ...... mmary tumor cell line, CMT-U27

@en

type

Item

label

Synergistic growth inhibitory ...... mmary tumor cell line, CMT-U27

@en

prefLabel

Synergistic growth inhibitory ...... mmary tumor cell line, CMT-U27

@en

P1476

Synergistic growth inhibitory ...... mmary tumor cell line, CMT-U27

@en

P2093

Fulya Üstün Alkan

http://www.w3.org/2001/XMLSchema#string

Funda Yildirim

http://www.w3.org/2001/XMLSchema#string

Gaye Erten

http://www.w3.org/2001/XMLSchema#string

Oya Üstüner

http://www.w3.org/2001/XMLSchema#string

Tülay Bakirel

http://www.w3.org/2001/XMLSchema#string

Utku Bakirel

http://www.w3.org/2001/XMLSchema#string

P2860

The role of COX-2 inhibition in breast cancer treatment and prevention

Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

Effects of cyclooxygenase inhibition on the gastrointestinal tract

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure

Molecular carcinogenesis of canine mammary tumors: news from an old disease

Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands

Drug combination studies and their synergy quantification using the Chou-Talalay method

Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.

Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice

Anti-Inflammatory Agents for Cancer Therapy.

P304

657-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1292/JVMS.15-0387

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Suzan Cinar

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292213357

http://www.w3.org/2001/XMLSchema#string

P698

26822118

http://www.w3.org/2001/XMLSchema#string

P932

4873858

http://www.w3.org/2001/XMLSchema#string

Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

about

P2860

P2860

Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932